
J&J’s Auris buy looks like a Verb swerve
Johnson & Johnson’s $3.4bn move for the robotic surgery specialist Auris Health could be bad news for its Verb Surgical joint venture.

Interview – CMR Surgical has $100m and a plan to keep busy
CMR Surgical has the cash to take it to CE mark.